ZoomMed Inc.: Change to the Board of Directors

ZoomMed Inc.: Change to the Board of Directors

ID: 411845

(firmenpresse) - MONTREAL, QUEBEC -- (Marketwired) -- 08/05/15 -- ZoomMed Inc. (TSX VENTURE: ZMD) (the "Corporation" or "ZoomMed") - The Corporation announces the resignation of Mr. Andre Marmet as director of the Corporation, effective immediately. Mr. Andre Marmet was serving on the Board of Directors since the incorporation of the Corporation in 2005. The Corporation and the Board of Directors thank Mr. Andre Marmet for his his contribution during the past ten years, both by his leadership and his valuable advice. Mr. Andre Marmet will continue his functions as Vice-President Corporate Business.

About ZoomMed

ZoomMed builds and operates "ZoomMed's communication network", a clinical information exchange platform between physicians and the various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical corporations and private insurers. The cornerstone of this network is ZoomMed's "ZRx Prescriber", a technological innovative Web application that greatly simplifies the writing of a prescription for the physician. Since it is a stand-alone product, it can easily be integrated to any Electronic Medical Record application (EMR).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Statements made in this news release that are not historical facts are "forward-looking statements" and readers are cautioned that any such statements are not guarantees of future performance, and that actual developments or results, may vary materially from those in these "forward-looking" statements.



Contacts:
Mr. Yves Marmet
President and Chief Executive Officer
(450) 678-5457, Ext 228



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  biOasis Announces the Successful Delivery to the CNS of an Enzyme Used to Treat Hunter Syndrome Prism Medical Ltd.: Grant of Incentive Options
Bereitgestellt von Benutzer: Marketwired
Datum: 05.08.2015 - 18:45 Uhr
Sprache: Deutsch
News-ID 411845
Anzahl Zeichen: 0

contact information:
Town:

MONTREAL, QUEBEC



Kategorie:

Medical Devices



Diese Pressemitteilung wurde bisher 174 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ZoomMed Inc.: Change to the Board of Directors"
steht unter der journalistisch-redaktionellen Verantwortung von

ZoomMed Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Annual and Special Shareholders Meeting of ZoomMed Inc. ...

MONTREAL, QUEBEC -- (Marketwired) -- 11/29/16 -- ZoomMed Inc. (TSX VENTURE: ZMD), announces it has held its Annual and Special Meeting of Shareholders on November 29, 2016.The meeting was held for the purpose of:Shareholders voted overwhelmingly in ...

ZoomMed Announces the Grant of Options ...

MONTREAL, QUEBEC -- (Marketwired) -- 01/21/16 -- ZoomMed inc. (TSX VENTURE: ZMD) announces that during its Board of directors held on January 15, 2016, the Board agreed to grant options allows its holder to purchase one common share of ZoomMed at a ...

Alle Meldungen von ZoomMed Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z